Ultimate magazine theme for WordPress.
BTC
$8,168.55
-2.06%
ETH
$179.55
-3.16%
LTC
$54.87
-3.24%
DASH
$71.47
-0.45%
XMR
$52.64
-1.18%
NXT
$0.01
ETC
$4.61
DOGE
$0.00
ZEC
$37.10
BTS
$0.03
DGB
$0.01
-5.77%
XRP
$0.29
-2.09%
BTCD
$20.52
PPC
$0.28
-3.96%
CRAIG
$0.00
XBS
$0.02
0%
XPY
$0.04
0%
PRC
$0.01
0%
YBC
$22.87
0%
DANK
$0.00

Top Losers: CAMAC Energy Inc (NYSEMKT:CAK), Avid Technology (NASDAQ:AVID), Microvision (NASDAQ:MVIS), Oculus Innovative Sciences (NASDAQ:OCLS)

103

CAMAC Energy IncUS-based oil and gas firm, CAMAC Energy Inc (NYSEMKT:CAK) has been listed on the Johannesburg stock exchange after an investment of $270 million by South Africa’s Public Investment Corporation (PIC) earlier this month, which mandated that CAMAC invest 10 per cent of its portfolio in Africa. On last trading day CAMAC Energy Inc (NYSEMKT:CAK) ended up 19.11% higher to close at $0.680 while trading in the range of $0.60 – $0.73. Its return on assets (ROA) is -7.00% while return on investment (ROI) is -4.80%. CAMAC Energy Inc (NYSEMKT:CAK) monthly performance is -54.67%.

TheStreet Ratings team rates Avid Technology, Inc. (NASDAQ:AVID) as a Sell with a ratings score of D. Avid Technology, Inc. (NASDAQ:AVID) in last trading activity ended up at $4.93 with day range of $4.80 – $6.70. Company weekly performance is -28.24% while its quarterly performance stands at -40.53%. Avid Technology, Inc. (NASDAQ:AVID) is -44.79% away from its 52 week high.

MicroVision, Inc. (NASDAQ:MVIS), today confirmed that its patented PicoP® display technology has been adopted as part of a pico projector module that a leading Fortune Global 100 consumers electronics company announced it is developing1. MicroVision has been supporting the Fortune Global 100 since April 2013 in its development of this high definition (HD) display engine. Microvision, Inc. (NASDAQ:MVIS) belongs to Technology sector with market capitalization of 77.93 M and has 0.70% insider ownership. In last trading activity company’s stock closed at $2.43 while opening price was $2.78.

Oculus Innovative Sciences Inc. (NASDAQ:OCLS) has announced a regulatory approval in Mexico for the company’s new Microcyn60 Oral Care family of products intended for use as an adjunct treatment in both mouth and throat infections.On Monday shares of Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) opened at $3.75 and closed at $3.50. This year Company’s Earnings per Share (EPS) growth is 30.50% and next year’s estimated EPS growth is 23.50%. Analysts mean target price for Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) is $9.00.

Comments